Colchicine Market - Forecast(2023 - 2028)

Colchicine is a drug used to treat gout disease and available as colcry, mitigare, zyclochin and so on brand names. It function is not to cure gout disease rather it prevents causing gout attacks. Also it is not an ordinary pain reliever and it can be used daily under doctor’s prescription. It is available in different forms. FDA government put a ban on Colchicine drug. U.S are the largest markets in colchicine market. 

Colchicine is an anti-gout, anti-inflammatory drug using from several years onwards. Its function is to lessen the uric acid in blood. It is available as different forms like tablets, capsules, ointment and so on. Preventing gout disease is primary function of colchicine drug. FMF (Familial Mediterranean fever) disease is also using this drug. The applications industries of this drug are chemical, pharmaceutical, agricultural and so on. 

Colchicine market report comprises of pricing analysis for different brands of colchicine available in the market. The average price of generic brand colchicine for o.6mg is around $180 to $202. The brand name colcrys has average price of $181-$264 and Mitigare has $192 to $229.  Different generic colchicine tablets varies from 10-30 rupees for 10 tablets of 0.5 mg. 

Geriatrics are suffered from gout attack. They prefer colchicine drug on daily basis. This is one of the driving force in the market that increases market growth. Daily consumption for curing FMF in adults and child 4 years old became driving force in this market. 

The price fluctuations of colchicine drug is a challenge in this market. After 2009, cost of this drug suddenly increases to $0.10 to $5. Researches are finding to reduce the cost of the drug comparing with generic colchicine drug. 

The base year of the study is 2017, with forecast done up to 2023. The study presents a thorough analysis of the competitive landscape, taking into account the market shares of the leading companies. It also provides information on unit shipments. These provide the key market participants with the necessary business intelligence and help them understand the future of the colchicine. The assessment includes the forecast, an overview of the competitive structure, the market shares of the competitors, as well as the market trends, market demands, market drivers, market challenges, and product analysis. The market drivers and restraints have been assessed to fathom their impact over the forecast period. This report further identifies the key opportunities for growth while also detailing the key challenges and possible threats. The key areas of focus include the types of colchicine market, and their specific applications in different types of vehicles.

Form of Colchicine Drug: Tablets, injection, capsule, ointment, cream. 

Applications of colchicine Drug: Gout diseases, Amyloidosis, Behcet's disease, Dermatitis herpetiformis, Familial Mediterranean fever (FMF), Paget's disease, Pericarditis, Pseudogout, Biliary and hepatic cirrhosis. 

End Users of colchicine Drug: Humans, Cows, Rats, Dogs, Others.

Douglas cole, president of Tadeka Pharmaceuticals U.S.A has shared his view on colchicine genic name and colcrys brand name. Their company Takeda made partnership with prasco laboratories and Westward companies and allow prasco Company to manufacture colcrys drug as same standard as colchicine drug to serve gout patients. 

Some of the other key players mentioned in this report are pubchem, drugbank.com, Himka, prasco, westward, cipla, Takeda Pharmaceuticals U.S.A., Hikma Pharmaceuticals PLC, Wockhard and few more companies.